Search research articles
Contact Us
Filters
Showing results (211-220 of 415) with videos related to
Page
of 42
Sort By:
Annals of Hematology
|
May 4, 2021
Profiling of bacterial bloodstream infections in hematological and oncological patients based on a comparative survival analysis
Sarah Weber, Aaron Magh, Michael Hogardt, et al.
Annals of Hematology
|
July 6, 2018
Bloodstream infections with gram-negative organisms and the impact of multidrug resistance in patients with hematological malignancies
Sebastian Scheich, Sarah Weber, Claudia Reinheimer, et al.
Infection and Immunity
|
May 4, 2011
Trimeric autotransporter adhesin-dependent adherence of Bartonella henselae, Bartonella quintana, and Yersinia enterocolitica to matrix components and endothelial cells under static and dynamic flow conditions
Niklas F Müller, Patrick O Kaiser, Dirk Linke, et al.
Antimicrobial Agents and Chemotherapy
|
December 19, 2007
Relative replication capacity and selective advantage profiles of protease inhibitor-resistant hepatitis C virus (HCV) NS3 protease mutants in the HCV genotype 1b replicon system
Yupeng He, Martin S King, Dale J Kempf, et al.
Microbiology Resource Announcements
|
July 2, 2024
Genome sequences of three <i>Bartonella schoenbuchensis</i> strains from Czechia
Luis Solis Cayo, Iva Hammerbauerová, Julian Sommer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 1, 1997
Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans
J F Denissen, B A Grabowski, M K Johnson, et al.
AIDS Research and Human Retroviruses
|
June 1, 1994
A C2 symmetry-based HIV protease inhibitor, A77003, irreversibly inhibits infectivity of HIV-1 in vitro
S Kageyama, D T Hoekzema, Y Murakawa, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 6, 2002
Synthesis and structure-activity relationships of a novel series of HIV-1 protease inhibitors encompassing ABT-378 (Lopinavir)
Hing L Sham, David A Betebenner, Xiaoqi Chen, et al.
Early Human Development
|
August 2, 2016
Group B streptococcus infections in neonates admitted to a German NICU: Emphasis on screening and adherence to pre-analytical recommendations
Claudia Reinheimer, Volkhard A J Kempf, Boris E Wittekindt, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 15, 2009
Synthesis and evaluation of inhibitors of cytochrome P450 3A (CYP3A) for pharmacokinetic enhancement of drugs
Charles A Flentge, John T Randolph, Peggy P Huang, et al.
Page
of 42
Search research articles
Search
Showing results (211-220 of 415) with videos related to
Sort By:
Page
of 42
Annals of Hematology
|
May 4, 2021
Profiling of bacterial bloodstream infections in hematological and oncological patients based on a comparative survival analysis
Sarah Weber, Aaron Magh, Michael Hogardt, et al.
Annals of Hematology
|
July 6, 2018
Bloodstream infections with gram-negative organisms and the impact of multidrug resistance in patients with hematological malignancies
Sebastian Scheich, Sarah Weber, Claudia Reinheimer, et al.
Infection and Immunity
|
May 4, 2011
Trimeric autotransporter adhesin-dependent adherence of Bartonella henselae, Bartonella quintana, and Yersinia enterocolitica to matrix components and endothelial cells under static and dynamic flow conditions
Niklas F Müller, Patrick O Kaiser, Dirk Linke, et al.
Antimicrobial Agents and Chemotherapy
|
December 19, 2007
Relative replication capacity and selective advantage profiles of protease inhibitor-resistant hepatitis C virus (HCV) NS3 protease mutants in the HCV genotype 1b replicon system
Yupeng He, Martin S King, Dale J Kempf, et al.
Microbiology Resource Announcements
|
July 2, 2024
Genome sequences of three <i>Bartonella schoenbuchensis</i> strains from Czechia
Luis Solis Cayo, Iva Hammerbauerová, Julian Sommer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 1, 1997
Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans
J F Denissen, B A Grabowski, M K Johnson, et al.
AIDS Research and Human Retroviruses
|
June 1, 1994
A C2 symmetry-based HIV protease inhibitor, A77003, irreversibly inhibits infectivity of HIV-1 in vitro
S Kageyama, D T Hoekzema, Y Murakawa, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 6, 2002
Synthesis and structure-activity relationships of a novel series of HIV-1 protease inhibitors encompassing ABT-378 (Lopinavir)
Hing L Sham, David A Betebenner, Xiaoqi Chen, et al.
Early Human Development
|
August 2, 2016
Group B streptococcus infections in neonates admitted to a German NICU: Emphasis on screening and adherence to pre-analytical recommendations
Claudia Reinheimer, Volkhard A J Kempf, Boris E Wittekindt, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 15, 2009
Synthesis and evaluation of inhibitors of cytochrome P450 3A (CYP3A) for pharmacokinetic enhancement of drugs
Charles A Flentge, John T Randolph, Peggy P Huang, et al.
Page
of 42